| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.8M | — | +35.4% |
| Cost of Revenue | $3.3M | — | +58.4% |
| Gross Profit | $5.5M | — | +24.4% |
| R&D Expense | $1.2M | — | -37.7% |
| SG&A Expense | $5.4M | — | -13.6% |
| Operating Income | -$4.9M | — | +92.4% |
| Pre-tax Income | -$4.5M | — | +93.0% |
| Income Tax | $39K | — | +168.4% |
| Net Income | -$4.5M | — | +92.9% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.4M | +3.9% | +6.0% |
| Accounts Receivable | $4.4M | +47.0% | +182.2% |
| Inventory | $5.9M | +6.0% | +9.6% |
| Current Assets | $60.0M | -6.3% | -18.0% |
| Total Assets | $121.5M | -4.3% | -15.0% |
| Current Liabilities | $8.6M | -9.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.3M | — | +20.9% |
| Capital Expenditures | $60K | — | -78.6% |
| Investing Cash Flow | $5.6M | — | -33.1% |
| Free Cash Flow | -$5.3M | — | +23.3% |
| +15.6% |
| Total Liabilities | $10.6M | -9.1% | +0.4% |
| Stockholders' Equity | $110.9M | -3.9% | -16.2% |